fasudil has been researched along with Anoxia-Ischemia, Brain in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q | 1 |
| Huang, XJ | 1 |
| He, W | 1 |
| Ding, J | 1 |
| Jia, JT | 1 |
| Fu, G | 1 |
| Wang, HX | 1 |
| Guo, LJ | 1 |
| Zhu, WW | 1 |
| Ma, XL | 1 |
| Guo, AL | 1 |
| Zhao, HY | 1 |
| Luo, HH | 1 |
2 other studies available for fasudil and Anoxia-Ischemia, Brain
| Article | Year |
|---|---|
Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium Channel Blockers; Cell Survival; Cer | 2009 |
Neuroprotective effects of NEP1-40 and fasudil on Nogo-A expression in neonatal rats with hypoxic-ischemic brain damage.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Newborn; Brain; Carotid Arteries; F | 2011 |